Antibody-–enzyme fusion proteins for cancer therapy
Antibody-–enzyme fusion proteins for cancer therapy
About this item
Full title
Author / Creator
Publisher
London: Future Medicine Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: Future Medicine Ltd
Subjects
More information
Scope and Contents
Contents
Advances in biomolecular technology have allowed the development of genetically fused antibody-–enzymes. Antibody-–enzyme fusion proteins have been used to target tumors for cancer therapy in two ways. In one system, an antibody-–enzyme is pretargeted to the tumor followed by administration of an inactive prodrug that is converted to its active for...
Alternative Titles
Full title
Antibody-–enzyme fusion proteins for cancer therapy
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1439237254
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1439237254
Other Identifiers
ISSN
1750-743X
E-ISSN
1750-7448
DOI
10.2217/imt.10.90
